Mutational landscape of non-muscle-invasive bladder cancer-Reference-Cited by-同舟云学术

Mutational landscape of non-muscle-invasive bladder cancer

Published:2018-11 Issue: Volume: Page:
ISSN:1078-1439
Container-title:Urologic Oncology: Seminars and Original Investigations
language:en
Short-container-title:Urologic Oncology: Seminars and Original Investigations

Author:

Hurst Carolyn D.,Knowles Margaret A.^ORCID

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference52 articles.

1. Cytogenetic analysis of 62 transitional cell bladder carcinomas;Granberg-Ohman;Cancer Genet Cytogenet,1984

2. Marked genetic differences between stage pTa and stage pT1 papillary bladder cancer detected by comparative genomic hybridization;Richter;Cancer Res,1997

3. Patterns of chromosomal imbalances in advanced urinary bladder cancer detected by comparative genomic hybridization;Richter;Am J Pathol,1998

4. The bladder cancer genome; chromosomal changes as prognostic makers, opportunities, and obstacles;Hoglund;Urol Oncol,2012

5. Novel tumor subgroups of urothelial carcinoma of the bladder defined by integrated genomic analysis;Hurst;Clin Cancer Res,2012

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of SPP1 as a Prognostic Biomarker and Immune Cells Modulator in Urothelial Bladder Cancer: A Bioinformatics Analysis;Cancers;2023-12-04

2. Primary Chemoablation for Intermediate-risk Low-grade Bladder Cancer: New Paradigm or Added Uncertainty?;Journal of Urology;2023-11

3. Heterogeneity of BCG unresponsive bladder cancer clinical trials limits patients’ access to novel therapeutics;Urologic Oncology: Seminars and Original Investigations;2023-09

4. The biological impacts of CEBPD on urothelial carcinoma development and progression;Frontiers in Oncology;2023-01-27

5. Tumour microenvironment landscape and immunotherapy response in bladder cancer decoded by stromal MOXD1 based on copper-related genes signature;Frontiers in Oncology;2022-12-22